Retatrutide is a powerful new weight loss drug from Eli Lily currently in clinical trials. Despite the clinical trials not yet being concluded, in April Eli Lilly and the FDA permitted one individual access to the drug through the FDA's compassionate use program, which gives patients with serious and immediately life-threatening medical issues access to experimental treatments. The patient was a 79-year old man with refractory obesity, obstructive sleep apnea, and pulmonary hypertension, high...

Read the original article